ストックスクリーナーアプリを入手
5.33
4.10%
0.21
アフターアワーズ：
5.33
Nuvation Bio Inc (NUVB) 最新ニュース
Why Is Nuvation Bio Back On Penny Stock Watchlists? - Kalkine Media
Nuvation Bio: David Hung's Latest Venture Looks Undervalued At Current Level (NYSE:NUVB) - Seeking Alpha
Nuvation Bio director Robert Mashal buys $118,250 in stock - Investing.com
Nuvation Bio (NUVB) director’s trust buys 25,000 Class A shares - Stock Titan
Nuvation Bio stock reiterated at Market Outperform by Citizens - Investing.com India
Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating - Moomoo
Spotlight On Promising Penny Stocks For June 2026 - simplywall.st
RBC Capital reiterates Nuvation Bio stock rating on ROS1 space value By Investing.com - Investing.com Australia
RBC Capital reiterates Nuvation Bio stock rating on ROS1 space value - Investing.com Nigeria
Nuvation Bio: Buy The Ibtrozi Launch (Rating Upgrade) (NYSE:NUVB) - Seeking Alpha
Nuvation Bio (NUVB) Presents Outcomes from TRUST-II Study - Insider Monkey
Nuvation Bio’s cancer drug sNDA accepted by FDA for review - Investing.com
5 Best Penny Stocks with Huge Upside Potential - Insider Monkey
RBC Capital raises Nuvation Bio stock price target on glioma potential - Investing.com
NUVB Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NUVB Stock Price, Quote & Chart | NUVATION BIO INC (NYSE:NUVB) - ChartMill
NUVB Q1 2026 Earnings: Modest EPS Beat Amid Continued Clinical ProgressEarnings Stability Report - newsline.com
Nuvation Bio Inc. Files Form 8-K with SEC Detailing Company Information and Annual Meeting Results - Minichart
Best Stocks Under $15 to Buy Right Now for High Growth Potential - Analytics Insight
Nuvation Bio execs to speak at Jefferies Healthcare Conference on June 3, 2026 - Pluang
Nuvation Bio to Present at the Jefferies Global Healthcare Conference - Investing News Network
Nuvation Bio (NUVB) shareholders elect directors, ratify KPMG and approve pay - Stock Titan
Nuvation Bio (NUVB) Reveals Promising Data from TRUST-II Study - GuruFocus
Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting - Investing News Network
Nuvation Bio presents quality of life data for IBTROZI at ASCO - Investing.com Nigeria
Nuvation Bio presents quality of life data for IBTROZI at ASCO By Investing.com - Investing.com South Africa
Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® (Taletrectinib) in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting - PR Newswire
Nuvation Bio Inc. (NUVB) director awarded 76,923 stock options in corrected filing - Stock Titan
Nuvation Bio (NASDAQ: NUVB) awards 123,397 stock options to director - Stock Titan
Nuvation Bio (NUVB) director gets 123,397 stock options at $4.79 - Stock Titan
Director at Nuvation Bio (NASDAQ: NUVB) awarded 123,397 stock options - Stock Titan
Nuvation Bio (NUVB) director Cui receives 123,397 stock options expiring 2036 - Stock Titan
NUVB: IBTROZI's rapid first-line growth and robust pipeline drive strong outlook and financial stability - TradingView
NUVB: IBTROZI's strong first-line growth and pipeline progress drive optimism for future expansion - TradingView
Truist Securities Initiates Coverage of Nuvation Bio (NUVB) with Buy Recommendation - MSN
Nuvation Bio (NUVB) Collaborates with Thermo Fisher - Insider Monkey
Nuvation Bio rises as B. Riley starts at Buy on launch trajectory for lead drug - MSN
NUVB: All proposals passed, including director elections and auditor ratification, with strong quorum - TradingView
Nuvation bid to expand Ibtrozi label undergoes FDA review - MSN
NUVB: IBTROZI and safusidenib drive growth, with new DDC platform updates and strong financial runway - TradingView
Nuvation Bio Sharpens IBTROZI Focus With Thermo Fisher And FDA Steps - Yahoo Finance
Are options traders betting on a big move in Nuvation Bio stock? - MSN
Earnings call transcript: Nuvation Bio Q1 2026 revenue beats forecast, stock jumps - Investing.com Nigeria
David Abrams's Nuvation Bio Inc(NUVB) Holding History - GuruFocus
Nuvation Bio Inc. (NUVB) reports next week: Wall Street expects earnings growth - MSN
Nuvation Bio Completes IBTROZI Manufacturing Tech Transfer to Thermo Fisher - Contract Pharma
Nuvation Bio Collaborates With Thermo Fisher Scientific For Lung Cancer Treatment - Moomoo
Nuvation Bio stock (US55043Q1004): Manufacturing deal with Thermo Fisher for lung cancer drug - AD HOC NEWS
Nuvation Bio To Collaborate With Thermo Fisher Scientific For U.S.-Based Manufacturing Of Ibtrozi For Ros1-Positive Non-Small Cell Lung Cancer - TradingView
2.60%
0.94%
大文字化:
|
ボリューム (24 時間):